Thank you for Subscribing to Cannabis Business Insights Weekly Brief
Cannabis Business Insights | Monday, August 24, 2026
Adding another CBD format may look like a simple way to reach a new group of customers. In practice, it can affect much more than the product catalogue. An oil and a topical product, for example, cannot always be managed as slightly different versions of the same item. Their formulations and packaging requirements introduce separate points where specifications can change, or records can lose their connection to the finished product.
From a sales perspective, a wider range offers clear appeal. It can create more price points and give retailers greater choice. The work behind each new item is less visible. Every format may need separate instructions and quality checks. Storage conditions or complaint records may also differ. Even a small addition to the range can create a surprising amount of follow-up work.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Existing product controls may not transfer neatly. A specification written for one format may leave important questions unanswered for another. The packaging might react differently to the formulation. Customers may also measure, apply or store the product in another way. Reusing documents without checking these differences can result in instructions that are technically correct but too general to be useful.
Managing suppliers becomes more complicated as well. CBD companies may rely on outside parties for ingredients and packaging, while manufacturing may take place elsewhere. A seemingly minor change to one input can affect several finished items. Unless the company knows exactly where that input is used, it may be difficult to identify which product records or packaging materials need to be reviewed.
Batch records provide the link between what was planned and what was actually produced. That link becomes harder to follow when information sits in separate files or moves between teams through informal updates. If a complaint is received later, staff may not be able to tell quickly whether it relates to one batch or points to a wider formulation problem.
Commercial pressure can make these gaps more likely. A retailer may offer shelf space on a tight schedule, encouraging the company to launch before every supporting process is settled. Waiting could mean losing the opportunity. Releasing the product too soon can lead to another kind of cost if labels or instructions have to be corrected after distribution starts.
Smaller CBD companies may find this particularly difficult because one employee often handles several parts of the process. Someone involved in developing the product might also review information supplied by an outside partner. This can speed up decisions, though it leaves less room for an independent check. A clear approval record at least shows who reviewed the change and what information was available at the time.
Complaint analysis can become fragmented as the catalogue expands. Reports about similar problems may sit under separate product names and appear unrelated. If the company reviews each format on its own, it may miss a pattern affecting more than one item.
The strength of a product range should not be measured only by how many items a CBD company can place on the market. It also depends on whether the business can still connect every item to the correct specification and production record. Expansion remains manageable only when the company can identify what changed before a small inconsistency reaches the rest of the range.
More in News